PharmaShots Weekly Snapshot (April 15-19, 2019)

1.Almac Diagnostic Collaborates with Queen’s University to Bring Personalized Chemotherapy for Esophageal Cancer

Published: April 18, 2019 | Tags: Almac Diagnostic, Collaborates, Queen’s University, Personalized Chemotherapy, Esophageal Cancer

2. NICE Publishes Final Recommendation for Almirall’s Ilumetri (tildrakizumab) to Treat Moderate-To-Severe Plaque Psoriasis in Adults

Published: April 17, 2019 | Tags: NICE, Publishes, Final Recommendation, Almirall, Ilumetri, tildrakizumab, Treat, Moderate-To-Severe, Plaque Psoriasis, Adults 

3.Mylan and TB Alliance Collaborate to Commercialize Pretomanid in Two Combination Regimens for Tuberculosis

Published: April 18, 2019 | Tags: Mylan, TB Alliance, Collaborates, Commercialize, Pretomanid, Two, Combination Regimens, Tuberculosis

4.AbbVie’s Skyrizi (risankizumab) Receives Health Canada’s Approval for Moderate to Severe Plaque Psoriasis

Published: April 18, 2019 | Tags:  AbbVie, Skyrizi, risankizumab, Receives, Health Canada, Approval, Moderate, Severe, Plaque Psoriasis

5.Pfizer & Eli Lilly Report Results of Tanezumab in Long-Term P-III Study for Osteoarthritis

Published: April 18, 2019 | Tags: Pfizer, Eli Lilly, Report, Results, Tanezumab, Long-Term, P-III, Study, Osteoarthritis, OA

6.World Health Organization (WHO) Reports 10 Guidelines on Digital Health Interventions

Published: April 17, 2019 | Tags: World Health Organization, WHO, Reports, 10, Guidelines, Digital Health Interventions

7.OncoSec Signs Research Agreement with Duke University School of Medicine to Evaluate the Combination of TAVOPLUS with a HER2-Plasmid Vaccine

Published: April 17, 2019 | Tags: OncoSec, Signs, Research Agreement, Duke University School of Medicine, Evaluate, Combination, TAVO, HER2-Plasmid Vaccine

8.Medtronic Reports Results of VenaSeal Closure System in VeClose Extension Study for Chronic Venous Diseases

Published: April 17, 2019 | Tags: Medtronic, Reports, Results, VenaSeal Closure System, VeClose Extension Study, Chronic Venous Diseases

9.CASI Pharmaceutical Signs an Exclusive Worldwide License Agreement with Black Belt for its TSK011010 Program

Published: April 17, 2019 | Tags: CASI Pharmaceutical, Signs, Exclusive, Worldwide, License, Agreement, Black Belt, TSK011010, Program

10.Boehringer Ingelheim Collaborates with PureTech to Develop Immuno-Oncology Candidates for Immune Modulation

Published: April 17, 2019 | Tags: Boehringer Ingelheim, Collaborates, PureTech, Develop, Immuno-Oncology, Product, Immune Modulation

11.FDA Orders Immediate Stop on Commercialization of Surgical Mesh for Women with Pelvic Collapse in the US

Published: April 16, 2019 | Tags:   FDA, Orders, Stop, Commercialization, Surgical Mesh, Pelvic Collapse, US

12.Gilead Collaborates with Insitro to Discover and Develop Novel Therapies in Nonalcoholic Steatohepatitis (NASH) for 3yrs.

Published: April 16, 2019 | Tags: Gilead, Collaborates, Insitro, Discover, Develop, Novel Therapies, Nonalcoholic Steatohepatitis, NASH, 3yrs

13.Thermo Fisher Collaborates with NX Prenatal to Develop Proteomics Assays for Adverse Pregnancy Outcomes

Published: April 16, 2019 | Tags: Thermo Fisher, Collaborates, NX Prenatal, Develop, Proteomics Assays, Adverse Pregnancy Outcomes     

14.Novartis Reports Results of Zolgensma (onasemnogene abeparvovec-xioi) in P-III STR1VE Study for Spinal Muscular Atrophy (SMA) Type 1

Published: April 16, 2019 | Tags: Novartis, Reports, Results, P-III, STR1VE Study, Zolgensma, onasemnogene abeparvovec-xioi, Spinal Muscular Atrophy, SMA, Type 1

15.Tessa Collaborates with Merck to Evaluate a Combination Therapy for Metastatic or Recurrent Cervical Cancer

Published: April 16, 2019 | Tags: Tessa, Collaborates, Merck, Evaluate, Combination Therapy, Metastatic, Recurrent, Cervical Cancer

16.Alnylam Initiates P-III ILLUMINATE-B Study of Lumasiran for Primary Hyperoxaluria Type 1 (PH1) in Pediatric Patients

Published: April 15, 2019 | Tags: Alnylam, Initiates, P-III, ILLUMINATE-B, Lumasiran, Primary Hyperoxaluria Type 1, PH1, Pediatric Patients     

17.Janssen Expands Clinical Development for Tremfya(R) (guselkumab) in Familial Adenomatous Polyposis (FAP)

Published: April 15, 2019 | Tags: Janssen, Expands, Clinical Development, Guselkumab, Tremfya(R),  Familial Adenomatous Polyposis, FAP      

18.Eagle Restructured its Licensing Agreement with Teva for Bendeka (bendamustine hydrochloride)

Published: April 15, 2019 | Tags: Eagle, Restructured, Licensing Agreement, Teva, Bendeka, bendamustine hydrochloride    

19.Castle Creek Collaborates with Fibrocell to Develop and Commercialize FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)     

Published: April 15, 2019 | Tags: Castle Creek, Collaborates, Fibrocell, Develop, Commercialize, FCX-007, Gene Therapy, Recessive Dystrophic Epidermolysis Bullosa, RDEB    

20.Novartis Reports FDA’s Acceptance of BLA for Brolucizumab (RTH258) to Treat Wet AMD

Published: April 15, 2019 | Tags: Novartis, Reports, FDA, Acceptance, BLA, Brolucizumab, RTH258, Treat, Wet AMD

21.Santhera to Present Result of DELOS & SYROS Study at the 2019 MDA Clinical and Scientific Conference

Published: April 15, 2019 | Tags:  Santhera; Present; Result; DELOS; SYROS; Study; 2019; Clinical; Scientific; Conference     

22.Dr. Reddy’s to Acquire a Portfolio of 42 Abbreviated New Drug Applications (ANDA) in the US

Published: April 13, 2019 | Tags:  Dr. Reddy’s, Acquire, 42, Abbreviated New Drug Applications, ANDA, US      

23.Tracon Terminates its P-III TAPPAS Trial of TRC105 (carotuximab) + Votrient (pazopanib) for Advanced or Metastatic Angiosarcoma

Published: April 12, 2019 | Tags:  Tracon, Terminate, P-III, TAPPAS Trial, TRC105, carotuximab, Votrient, pazopanib, Advanced, Metastatic Angiosarcoma      

24.Alnylam Reports Results of Givosiran in P-III ENVISION Study to Treat Acute Hepatic Porphyria

Published: April 12, 2019 | Tags: Alnylam, Reports, Results, Givosiran, P-III, ENVISION, Study, Treat Acute Hepatic Porphyria       

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post